ArticleNoro psikiyatri arsivi2019

A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial.

Gülşen Akman Demır et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.